Dr. Anand is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
221 Longwood Ave
Boston, MA 02115- Is this information wrong?
Summary
- Dr. Anand is Professor of Medicine at the Cleveland Clinic Lerner College of Medicine. He holds the position of Vice-chair for Research for the Center for Behavioral Health and directs the Mood and Emotional Disorders Across the Life Span (MEDALS) program at the Cleveland Clinic.
Dr. Anand completed his initial medical and psychiatric training from the All India Institute of Medical Sciences and the Royal Australian and New Zealand College of Psychiatrists. In 1992, he came to Yale University School of Medicine where he completed a Clinical Neuroscience fellowship. Subsequently he joined the Yale University School of Medicine faculty as assistant professor and directed the bipolar disorders clinical and research program there.
While at Yale, Dr. Anand completed several innovative brain imaging and pharmacological studies on the biological basis of mood disorders. In 2001, he was offered a tenured professorship appointment at Indiana University School of Medicine and he established the mood disorders clinical and research program there. At Indiana University School of Medicine he conducted pioneering studies of abnormalities in brain connectivity in mood disorders and was funded by the National Institutes of Health.
Dr. Anand moved to Cleveland Clinic in 2012 where he has established a diverse clinical research program in the areas of personalized medicine, brain imaging, and novel treatment trials for mood and other neuropsychiatric disorders. Dr. Anand has obtained several NIH grants as well as private foundation grants and has also conducted numerous clinical trials. He has published extensively in the areas of brain imaging and psychopharmacology of mood disorders and is nationally and internationally recognized in these areas.
Education & Training
- Griffin HospitalResidency, Internal Medicine, 1994 - 1994
- Yale-New Haven HospitalFellowship, Clinical Neuroscience, 1992 - 1994
- Royal Australian and New Zealand College of PsychiatristsFRANZCP, Psychiatry, 1986 - 1991
- All India Institute of Medical SciencesClass of 1985
Certifications & Licensure
- OH State Medical License 2012 - 2025
- MA State Medical License 2021 - 2024
- IN State Medical License 2001 - 2017
- CT State Medical License 1993 - 2007
- American Board of Psychiatry and Neurology Psychiatry
Clinical Trials
- Differentiating Unipolar and Bipolar Depression in Young Adults Using fMRI Start of enrollment: 2011 Nov 01
- Genomics Used to Improve DEpression Decisions Start of enrollment: 2014 Apr 01
- Structural and Functional Connectivity of Brainstem Monoamine Pathways in Treatment Resistant Depression Start of enrollment: 2016 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsChoosing Between Ketamine and Electroconvulsive Therapy for Outpatients With Treatment-Resistant Depression-Advantage Ketamine?Sanjay J Mathew, Manish K Jha, Amit Anand> ;JAMA Psychiatry. 2023 Dec 1
- 8 citationsFocal adhesion is associated with lithium response in bipolar disorder: evidence from a network-based multi-omics analysis.Vipavee Niemsiri, Sara Brin Rosenthal, Caroline M Nievergelt, Adam X Maihofer, Maria C Marchetto, Renata Santos, Tatyana Shekhtman, Ney Alliey-Rodriguez, Amit Anand, Y...> ;Molecular Psychiatry. 2023 Mar 29
- 1 citationsThe therapeutic use and efficacy of ketamine in alcohol use disorder and alcohol withdrawal syndrome: a scoping review.Charlotte E Goldfine, Jeremiah J Tom, Dana D Im, Benjamin Yudkoff, Amit Anand, Joseph J Taylor, Peter R Chai, Joji Suzuki> ;Frontiers in Psychiatry. 2023 Jan 1
- Join now to see all
Authored Content
- The High Price of Ignoring Disease in the MarginalizedJuly 2020
- The High Price of Ignoring Disease in the MarginalizedJuly 2020
Press Mentions
- Ketamine Shows Promise for Hard-to-Treat Depression in New StudyMay 26th, 2023
- Ketamine Beats Shock Therapy in Easing Tough-to-Treat DepressionMay 25th, 2023
- Ketamine as Effective as Electroconvulsive Therapy for Treatment-Resistant DepressionMay 25th, 2023
- Join now to see all
Hospital Affiliations
- Brigham and Women's HospitalBoston, Massachusetts
- Massachusetts General HospitalBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: